Man, Yim
GlaxoSmithKline (United Kingdom)
3 papers on CoChatORCID 0000-0003-0941-478X
Most cited papers
- Verified
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases
Cited by 206
- Verified
Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis
John, A. E., Graves, R. H., Pun, K. T., Vitulli, G., Forty, E. J., Mercer, P. F., Morrell, J. L., Barrett, J. W., Rogers, R. F., Hafeji, M., et al. (2020) · Nature Communications
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisCell Adhesion Molecules Research
Cited by 131
- Verified
Loss of Epithelial Integrity Resulting from E-Cadherin Dysfunction Predisposes Airway Epithelial Cells to Adenoviral Infection
Man, Y., Hart, V. J., Ring, C. J. A., Sanjar, S., & West, M. R. (2000) · American Journal of Respiratory Cell and Molecular Biology
Cell Adhesion Molecules ResearchBarrier Structure and Function Studies
Cited by 69
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free